Renee Gagnon, Founder and CEO of HollyWeed North Cannabis Inc. today (“HollyWeed”) today announced the appointment of Kimberley Ellis to the position of Vice President, Business Development for the company.


In her new position, Ellis will bring her results-driven sales skills, extensive experience pitching, winning and delivering profitable solutions to HollyWeed. As a fierce competitor and data-driven business developer, Ellis is adept at identifying and realizing growth opportunities and securing revenue pipelines.

Prior to joining HollyWeed North Cannabis Inc., Ellis was at Bell Media representing CTV, Canada’s # 1 Television Network. During her tenure at Bell Media she delivered $25M+ in annual revenue, introduced and garnered repeat revenue for CTV Two, secured and grew NFL and MasterChef Sponsorships, achieved +40% increase in Specials revenue and +35% increase in alternate revenue streams. Ellis has also held positions at Moffat Communications’ Women’s Television Network, Corus, Rogers and began her career in advertising. Ellis has been actively involved in the Canadian cannabis industry, volunteering at cannabis events and functions to stay in the know with changes to the market and regulations.

In making the announcement, Renee Gagnon, Founder and CEO of HollyWeed North Cannabis LTD states: “We are thrilled to have Kimberley join the HWN team. Her experience and knowledge are in incredible asset and addition to our team and I look forward to working with her to further expand and grow the company.”

Adds Ellis: “I am excited to join HWN as I am passionate about the future of cannabis and business, and look forward to cultivating new relationships and successful partnerships on behalf of HollyWeed North Cannabis Inc.”

About HollyWeed North Cannabis Inc.

HollyWeed North is a private Canadian company incorporated in British Columbia, established in 2016, with operating subsidiaries specializing in the growth, manufacturing, licensing and production of cannabis and other pharma grade products. HollyWeed North’s subsidiaries include HollyWeed Manufacturing and Extracts Inc., a federally dealers’ licensed company incorporated in British Columbia specializing in cannabis extraction and product manufacturing; HollyWeed Grow Inc., a late stage federal ACMPR applicant, also a private company incorporated in British Columbia specializing in the growth of medical cannabis and cannabis products; HollyWeed Retail Inc., a retail strategies provider and supply chain management company incorporated in British Columbia; Hollyweed Bakery Inc., a developer and manufacturer of unique cannabis baked goods and edibles incorporated in British Columbia; and TerraCube International Inc., a manufacturer and developer of proprietary scalable, sanitary grow facilities incorporated in British Columbia. HollyWeed North is currently restructuring its capital such that, upon execution of the Definitive Agreement, all the subsidiaries will be wholly-owned by HollyWeed North.

Contact: Deborah Radel at DRPR, deborah@drpr.us

SOURCE: HollyWeed North Cannabis Inc.

Source: www.accesswire.com

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action.

Keep reading... Show less

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less